Flamel Technologies S.A. (ADR) (NASDAQ:FLML)
CAPS Rating:
A biopharmaceutical company principally engaged in the development of two unique polymer-based drug delivery technologies for the improvement of medical applications.
RSS Headlines
Fool UK
Recs
It would be difficult for me to be more wrong about a stock than I was with this one. I got caught up in the "potential" of their technology and ignored their poor execution.